SAN DIEGO, March 31, 2015 (GLOBE NEWSWIRE) -- ICON Vapor, Inc. (OTCPK:ICNV) is pleased to announce that the company has filed the application with OTC Markets to move ICNV from the PK to QB markets.
Icon Vapor, Inc. has made great strides over the first quarter of 2015 in further developing the company and sales structure. Icon Vapor's CEO, Dan Balsiger stated, "With the acquisition of Green Tree Syndicate completed at the end of the fourth quarter of 2014, and with the implementation of our sales and marketing programs as highlighted on previous press releases as well as becoming a fully reporting company with the filing of our Form 10 with the SEC, the logical next step was to move the ICNV ticker from the PK to the QB markets."
Dan went on to say, "we are working extremely hard and anticipate strong quarter to quarter performance of our company throughout 2015 and 2016, and we look forward to being as transparent as possible to our shareholders. Elevating the Company from the PK to the QB will provide clearer information to our shareholder base, which is extremely important to us."
About ICON Vapor, Inc.:
Headquartered in San Diego, California, ICON Vapor, Inc. engages in the manufacture and distribution of Ultra Premium Vapor Products. The company offers a wide variety of Vapor Products, Vape Pens & E-Liquids that are made in the USA, all branded under the ICON Vapor Products line. For further information please contact the Company at: ir@iconvapor.com.
Safe Harbor Statement:
This press release may contain forward looking statements and or observations which are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues as well as any payment of dividends on our stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. These risks and uncertainties include but not limited to information as contained within the Company's most current quarterly reports, annual reports, and or other such filings as may be accessed through the OTC website. Furthermore, the Company disclaims any intention or obligation to update or revise any such forward looking statements, whether as a result of new information, future events, or otherwise. We have incurred and will continue to incur significant expenses in our expansion of our existing as well as new product lines noting there is no assurance that we will generate enough revenues to offset those costs. Additional product offerings may expose us to additional legal and regulatory costs and unknown exposure(s) based upon the variables as associated with the general business channel we are operating in, the impact of which cannot be predicted at this time including risks as associated with our product and recent FDA pronouncements.